Article citationsMore>>

Zheng, Y., Yang, X., Yan, C., Feng, R., Sah, B.K., Yang, Z., et al. (2020) Effect of Apatinib plus Neoadjuvant Chemotherapy Followed by Resection on Pathologic Response in Patients with Locally Advanced Gastric Adenocarcinoma: A Single-Arm, Open-Label, Phase II Trial. European Journal of Cancer, 130, 12-19.
https://doi.org/10.1016/j.ejca.2020.02.013

has been cited by the following article:

• TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

  KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

  ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.